Studies demonstrated that SNAT1 is overexpressed in colorectal cancer [16], breast cancer [14], HCC [17], gastric cancer [18], osteosarcoma [13], acute myeloid leukemia (AML) [19], and endometrial cancer [20]. Here, SLC38A1 is linked to breast carcinoma.